Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Nasus Pharma Ltd. ( (NSRX) ).
On March 5, 2026, Nasus Pharma held a Special General Meeting of Shareholders at which a quorum was present and investors approved all items on the agenda, including an amendment and restatement of the Articles of Association to increase the company’s authorized share capital. The updated Articles, formally adopted as of March 5 and filed with the U.S. Securities and Exchange Commission on March 6, 2026, enhance Nasus Pharma’s flexibility to issue additional shares in the future, potentially supporting capital-raising activities and strategic transactions for the benefit of shareholders.
By securing shareholder backing for a larger authorized share pool and refreshed governing documents, Nasus Pharma has strengthened its corporate toolkit for future financing or expansion moves within the constraints of Israeli corporate law. The resolutions passed at the March 5 meeting, and the subsequent filing of the amended Articles, underscore the company’s intent to maintain readiness for growth initiatives while aligning its capital structure and governance practices with public-company requirements in both Israel and the United States.
The most recent analyst rating on (NSRX) stock is a Buy with a $19.00 price target. To see the full list of analyst forecasts on Nasus Pharma Ltd. stock, see the NSRX Stock Forecast page.
More about Nasus Pharma Ltd.
Nasus Pharma Ltd., based in Tel Aviv, is an Israeli public company operating under the Israeli Companies Law as a foreign private issuer in the U.S. capital markets. The company’s share capital is composed of no-par-value ordinary shares, and its corporate governance framework is set out in its Articles of Association, which regulate shareholder meetings, board structure and capital actions.
Average Trading Volume: 6,401
Technical Sentiment Signal: Strong Sell
For detailed information about NSRX stock, go to TipRanks’ Stock Analysis page.